900 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
Rank Status Study
21 Recruiting Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Conditions: Diabetes Mellitus, Type 2;   Hypertension
Interventions: Drug: Canagliflozin;   Drug: Placebo
22 Not yet recruiting Linagliptin Inpatient Trial
Condition: Type 2 Diabetes
Interventions: Drug: Linagliptin;   Drug: Basal Bolus;   Drug: Linagliptin + glargine 50%;   Drug: Linagliptin + 80% Glargine
23 Recruiting Association of Kisspeptin Levels With Insulin Secretion in Diabetes Mellitus
Condition: Diabetes Mellitus
Intervention:
24 Not yet recruiting Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Insulin human
25 Recruiting Observational Registry for Basal Insulin Treatment Study (ORBIT)
Condition: Diabetes
Intervention:
26 Recruiting Hypoglycemia and Autonomic Nervous System Function
Condition: Hypoglycemia
Interventions: Drug: Eplerenone;   Drug: Placebo
27 Recruiting Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Vildagliptin followed by Sitagliptin;   Drug: Sitagliptin followed by Vildagliptin
28 Recruiting Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes
Interventions: Drug: Dehydroepiandrosterone;   Drug: Placebo
29 Recruiting Genetic Variation in the Transporters and Hypoglycemic Agents
Condition: Type 2 Diabetes
Intervention:
30 Recruiting Comparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Behavioral: Active titration algorithm;   Behavioral: Usual titration algorithm
31 Recruiting Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Disease
Interventions: Drug: Liraglutide;   Drug: Sitagliptin
32 Recruiting Evaluate Safety of TI in Diabetic Subjects With Moderate Obstructive Pulmonary Disease (Asthma and COPD)
Conditions: Diabetic Type 1 With Asthma or COPD;   Diabetic Type 2 With Asthma or COPD;   Type 1 Diabetes;   Type 2 Diabetes;   Indeterminate Obstructive Lung Disease
Interventions: Drug: Technosphere Insulin;   Drug: Usual Care
33 Recruiting Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE;   Drug: Metformin;   Drug: DPP-4 inhibitor;   Drug: Sulphonylurea
34 Recruiting A Study of the Safety and Efficacy of MK-3102 in ≥18 and <45 Year-Old Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028 AM1)
Condition: Diabetes Mellitus
Interventions: Drug: MK-3102;   Drug: Placebo to MK-3102;   Drug: Metformin
35 Recruiting Effects of Alogliptin on Pancreatic Beta Cell Function
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin;   Drug: Metformin 750 mg
36 Recruiting The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication and Abnormal Glucose Metabolism
Conditions: Peripheral Arterial Disease;   Intermittent Claudication;   Glucose Metabolism Disorders
Interventions: Drug: Metformin;   Drug: Placebo
37 Unknown  The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1
Condition: Pharmacogenetics of Metformin
Intervention: Drug: Metformin
38 Recruiting Liraglutide as add-on to Insulin in Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: Liraglutide;   Drug: Placebo
39 Recruiting Study to Evaluate the Safety and Efficacy of the Addition of MK-3102 Compared With the Addition of Sitagliptin in Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)
Condition: Type 2 Diabetes
Interventions: Drug: MK-3102;   Drug: Sitagliptin;   Drug: Placebo to MK-3102;   Drug: Placebo to Sitagliptin;   Drug: Open-label Metformin;   Drug: Open-label Glimepiride
40 Recruiting A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years